This compound is a pharmaceutical intermediate consisting of a tert-butyl carbamate-protected amino alcohol combined with succinic acid as a salt-forming agent. It is used in research and manufacturing settings for the synthesis of more complex active pharmaceutical ingredients.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 169870-02-4
Bdh succinate
Pharmaceutical intermediate for HIV protease inhibitors
Carbamic acid, N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-, 1,1-dimethylethyl ester
Pharmaceutical intermediate for peptide synthesis
Methyl 4,4'-biphenyl-R-alanate
Pharmaceutical intermediate for drug synthesis
(4'-Methyl-3-fluoro[1,1'-biphenyl]-4-yl)-boronic acid
pharmaceutical intermediate
(5R)-ethyl 5-((1R,3aS,7aR)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethyl)-7a-methyloctahydro-1H-inden-1-yl)hexanoate
Calcitriol intermediate
2,4-Dichloro-6-phenyl-1,3,5-triazine
Pharmaceutical intermediate
(3-(6-Phenylhexyl)phenyl)boronic acid
n.a
1,6-Diphenylhexane
n.a
butanedioic acid;tert-butyl N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]carbamate
ZICUGSIJUKRRJL-OCIDDWSYSA-N
CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)N)O.C(CC(=O)O)C(=O)O